Omada Health, Inc. (OMDA) stock
OMDANasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 13/3056% above fair value
$14.33−0.37 (-2.52%)
Close on Nov 13, 2026Market cap $877.24MP/E –Yield –
Omada Health r&d expenses
Research and development expenses are spending on new products and technology.
Omada Health's R&D Expenses for the twelve months ending Sep 30, 2026 was $54.15M, up 41.3% year over year. For fiscal 2025 it was $40.68M, up 13.3% from the year before.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $40.68M | +13.3% |
| FY2024 | Dec 31, 2024 | $35.92M | +6.5% |
| FY2023 | Dec 31, 2023 | $33.74M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $15.27M | +48.2% |
| Q2 FY2026 | Jun 30, 2026 | $14.63M | +45.9% |
| Q1 FY2026 | Mar 31, 2026 | $12.70M | +44.2% |
| Q4 FY2025 | Dec 31, 2025 | $11.55M | +25.7% |
| Q3 FY2025 | Sep 30, 2025 | $10.30M | +16.4% |
| Q2 FY2025 | Jun 30, 2025 | $10.02M | +11.5% |
| Q1 FY2025 | Mar 31, 2025 | $8.81M | – |
| Q4 FY2024 | Dec 31, 2024 | $9.19M | – |
| Q3 FY2024 | Sep 30, 2024 | $8.85M | – |
| Q2 FY2024 | Jun 30, 2024 | $8.99M | – |
See a number that looks wrong?